Focus research 2022 DynAct team
Advances in cytotoxic T lymphocyte function IOver the past year, the DynAct team’s research has progressed along three main lines:
- In collaboration with the ATTACK consortium funded by the prestigious European ERC Synergy Grant, the team has helped characterize the lytic compartment of cytotoxic T lymphocytes (CTL). Read article
- The team has shed new light on the molecular mechanisms by which aggressive tumors such as melanoma resist CTL attack at the lytic synapse. Read the article
- In collaboration with Dr. Sylvain Cussat-Blanc (Institut de Recherche en Informatique de Toulouse – IRIT), the team has developed a new approach to instance segmentation in microscopy that takes advantage of the highly innovative application called Cartesian Genetic Programming (CGP) of biological images. A patent application has been filed for this program and an article has been submitted for publication (K. Cortacero et al, under revision).
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here
![logo_crct_v-1 Centre de Recherches en Cancérologie de Toulouse](https://www.crct-inserm.fr/wp-content/uploads/2021/03/logo_crct_v-1.png)
Centre de Recherches contre le Cancer de Toulouse (Oncopole)
Toulouse - FR
Nous contacter
+33 5 82 74 15 75
Nous rejoindre ?
![InsermSeul_Rvb__noir](https://www.crct-inserm.fr/wp-content/uploads/2022/01/InsermSeul_Rvb__noir.png)
![Logo-CNRS](https://www.crct-inserm.fr/wp-content/uploads/2021/08/Logo-CNRS.png)
![logo-ut3](https://www.crct-inserm.fr/wp-content/uploads/2023/03/logo-ut3.jpg)